Search Results - "Djeridane, Malika"

Radioimmunotherapy of refractory or relapsed Hodgkinʼs lymphoma with 90Y-labelled antiferritin antibody by Decaudin, Didier, Levy, Raphaël, Lokiec, François, Morschhauser, Franck, Djeridane, Malika, Kadouche, Jean, Pecking, Alain

“…The aim of this study was to evaluate the safety and efficacy of radiolabelled rabbit polyclonal antiferritin antibody in relapsed or refractory Hodgkinʼs…”
Get full text

Comparison of initial characteristics and long-term outcome of patients with lymphocyte-predominant Hodgkin lymphoma and classical Hodgkin lymphoma at clinical stages IA and IIA prospectively treated by brief anthracycline-based chemotherapies plus extended high-dose irradiation by Feugier, Pierre, Labouyrie, Eric, Djeridane, Malika, Jenabian, Arash, Dubruille, Viviane, Berthou, Christian, Ghandour, Christiane, Desablens, Bernard, Chaït, Yasmine, Casassus, Philippe, Delwail, Vincent, Ifrah, Norbert, Le Mevel, Annick, Lamy, Thierry, Brière, Josette, Colonna, Pierre, Andrieu, Jean-Marie

“…Lymphocyte-predominant Hodgkin lymphoma (LPHL), according to the Revised European-American Lymphoma classification, was considered on a retrospective basis as…”
Get full text

Predictive and discriminating three‐risk‐group prognostic scoring system for staging Hodgkin lymphomas by Maucort‐Boulch, Delphine, Djeridane, Malika, Roy, Pascal, Riche, Benjamin, Colonna, Pierre, Andrieu, Jean‐Marie

“…BACKGROUND. Several 3‐stage Ann Arbor classification‐derived prognostic systems were constructed since 1980 to identify the prognosis of Hodgkin lymphoma (HL)…”
Get full text

Radioimmunotherapy (RIT) of Refractory or Relapsed Hodgkin's Lymphoma (HL) with 90Yttrium-Labelled Antiferritin Antibody by Decaudin, Didier, Lévy, Rafaël, Lokiec, François, Madar, Olivier, Brossel, Rémi, Morschhauser, Franck, Songeur, Valentine, Djeridane, Malika, Kadouche, Jean, Pecking, Alain

“…The aim of this study was to evaluate the safety and efficacy of radiolabelled DTPA-chelated rabbit polyclonal antiferritin antibody (Ab) in relapsed or…”
Get full text

Treatment of patients with advanced or bulky Hodgkin disease with a 12-week doxorubicin, bleomycin, vinblastine, and dacarbazine-like chemotherapy regimen followed by extended-field, full-dose radiotherapy: long-term results of the Groupe Ouest et Est des Leucémies et Autres Maladies de Sang H90-A/B Multicenter Randomized Trial by Djeridane, Malika, Oudard, Stéphane, Escoffre-Barbe, Martine, Lacotte-Thierry, Laurence, Desablens, Bernard, Briére, Jean, Dib, Mamoun, Cassasus, Philippe, Ghandour, Christiane, Lamy, Thierry, Lejeune, Françoise, Simon, Marc, Traullé, Catherine, Vigier, Magda, Maisonneuve, Henri, Briére, Josette, Colonna, Pierre, Andrieu, Jean-Marie

“…This Phase II study was performed in patients with advanced or bulky Hodgkin disease (HD) to evaluate the results of a 7-drug chemotherapy (CT) regimen that…”
Get full text

Treatment of patients with advanced or bulky Hodgkin disease with a 12‐week doxorubicin, bleomycin, vinblastine, and dacarbazine‐like chemotherapy regimen followed by extended‐field, full‐dose radiotherapy by Djeridane, Malika, Oudard, Stéphane, Escoffre‐Barbe, Martine, Lacotte‐Thierry, Laurence, Desablens, Bernard, Briére, Jean, Dib, Mamoun, Cassasus, Philippe, Ghandour, Christiane, Lamy, Thierry, Lejeune, Françoise, Simon, Marc, Traullé, Catherine, Vigier, Magda, Maisonneuve, Henri, Briére, Josette, Colonna, Pierre, Andrieu, Jean‐Marie

“…BACKGROUND This Phase II study was performed in patients with advanced or bulky Hodgkin disease (HD) to evaluate the results of a 7‐drug chemotherapy (CT)…”
Get full text